Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 61
Filter
1.
N Engl J Med ; 342(24): 1766-72, 2000 Jun 15.
Article in English | MEDLINE | ID: mdl-10852998

ABSTRACT

BACKGROUND: After patients have undergone colonoscopic polypectomy, it is uncertain whether colonoscopic examination or a barium enema is the better method of surveillance. METHODS: As part of the National Polyp Study, we offered colonoscopic examination and double-contrast barium enema for surveillance to patients with newly diagnosed adenomatous polyps. Although barium enema was performed first, the endoscopist did not know the results. RESULTS: A total of 973 patients underwent one or more colonoscopic examinations for surveillance. In the case of 580 of these patients, we performed 862 paired colonoscopic examinations and barium-enema examinations that met the requirements of the protocol. The findings on barium enema were positive in 222 (26 percent) of the paired examinations, including 139 of the 392 colonoscopic examinations in which one or more polyps were detected (rate of detection, 35 percent; 95 percent confidence interval, 31 to 40 percent). The proportion of examinations in which adenomatous polyps were detected by barium enema colonoscopy was significantly related to the size of the adenomas (P=0.009); the rate was 32 percent for colonoscopic examinations in which the largest adenomas detected were 0.5 cm or less, 53 percent for those in which the largest adenomas detected were 0.6 to 1.0 cm, and 48 percent for those in which the largest adenomas detected exceeded 1.0 cm. Among the 139 paired examinations with positive results on barium enema and negative results on colonoscopic examination in the same location, 19 additional polyps, 12 of which were adenomas, were detected on colonoscopic reexamination. CONCLUSIONS: In patients who have undergone colonoscopic polypectomy, colonoscopic examination is a more effective method of surveillance than double-contrast barium enema.


Subject(s)
Adenoma/diagnosis , Barium Sulfate , Colonic Polyps/diagnosis , Colonoscopy , Enema , Adenoma/surgery , Colonic Polyps/surgery , False Negative Reactions , Female , Humans , Male , Middle Aged , Recurrence , Single-Blind Method
2.
N Engl J Med ; 334(2): 82-7, 1996 Jan 11.
Article in English | MEDLINE | ID: mdl-8531963

ABSTRACT

BACKGROUND: The adenoma-adenocarcinoma sequence in colorectal cancer suggests an increased risk of colorectal cancer in the families of patients with adenomatous polyps. METHODS: A random sample of participants in the National Polyp Study who had newly diagnosed adenomatous polyps were interviewed for information on the history of colorectal cancer in their parents and siblings. The risk of colorectal cancer in family members was analyzed according to the characteristics of the patients with adenomas and in comparison with a sample of patients' spouses, who served as controls. RESULTS: Among the patients with adenomas, 1199 provided information on whether they had a family history of colorectal cancer. After the exclusion of families for which information was incomplete and of 48 patients who had been referred for colonoscopy solely because they had a family history of colorectal cancer, there were 1031 patients with adenomas, 1865 parents, 2381 siblings, and 1411 spouse controls. The relative risk of colorectal cancer, adjusted for the year of birth and sex, was 1.78 for the parents and siblings of the patients with adenomas as compared with the spouse controls (95 percent confidence interval, 1.18 to 2.67). The relative risk for siblings of patients in whom adenomas were diagnosed before 60 years of age was 2.59 (95 percent confidence interval, 1.46 to 4.58) as compared with the siblings of patients who were 60 or older at the time of diagnosis and after adjustment for the sibling's year of birth and sex and a parental history of colorectal cancer. The risk increased with decreasing age at the time of the diagnosis of adenoma (P for trend < 0.001). The relative risk for the siblings of patients who had a parent with colorectal cancer, as compared with those who had no parent with cancer, was 3.25 (95 percent confidence interval, 1.92 to 5.52), after adjustment for the sibling's year of birth and sex and the patient's age at diagnosis. CONCLUSIONS: Siblings and parents of patients with adenomatous polyps are at increased risk for colorectal cancer, particularly when the adenoma is diagnosed before the age of 60 or--in the case of siblings--when a parent has had colorectal cancer.


Subject(s)
Adenomatous Polyps/genetics , Colorectal Neoplasms/genetics , Adult , Aged , Case-Control Studies , Colonic Neoplasms/epidemiology , Colonic Neoplasms/genetics , Colorectal Neoplasms/epidemiology , Female , Humans , Incidence , Life Tables , Male , Middle Aged , Nuclear Family , Proportional Hazards Models , Random Allocation , Risk , Risk Factors
3.
Hum Pathol ; 25(1): 98-101, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8314265

ABSTRACT

A case is presented of an elderly man with a striking and unusual form of colonic schistosomiasis consisting of extensive large nodules on the serosal surface of the distal large bowel. The nodules were composed almost entirely of Schistosoma mansoni ova surrounded by thick bands of fibrous tissue. Although the English language literature describes various manifestations of intestinal and abdominal schistosomiasis, nowhere is there an adequate description of this unusual presentation, which might be confused with subserosal metastatic malignancy or diverticulosis during surgical examination.


Subject(s)
Colonic Diseases/pathology , Schistosoma mansoni , Schistosomiasis/pathology , Aged , Animals , Colonic Diseases/parasitology , Humans , Male , Schistosoma mansoni/isolation & purification , Schistosomiasis/parasitology
4.
N Engl J Med ; 329(27): 1977-81, 1993 Dec 30.
Article in English | MEDLINE | ID: mdl-8247072

ABSTRACT

BACKGROUND: The current practice of removing adenomatous polyps of the colon and rectum is based on the belief that this will prevent colorectal cancer. To address the hypothesis that colonoscopic polypectomy reduces the incidence of colorectal cancer, we analyzed the results of the National Polyp Study with reference to other published results. METHODS: The study cohort consisted of 1418 patients who had a complete colonoscopy during which one or more adenomas of the colon or rectum were removed. The patients subsequently underwent periodic colonoscopy during an average follow-up of 5.9 years, and the incidence of colorectal cancer was ascertained. The incidence rate of colorectal cancer was compared with that in three reference groups, including two cohorts in which colonic polyps were not removed and one general-population registry, after adjustment for sex, age, and polyp size. RESULTS: Ninety-seven percent of the patients were followed clinically for a total of 8401 person-years, and 80 percent returned for one or more of their scheduled colonoscopies. Five asymptomatic early-stage colorectal cancers (malignant polyps) were detected by colonoscopy (three at three years, one at six years, and one at seven years). No symptomatic cancers were detected. The numbers of colorectal cancers expected on the basis of the rates in the three reference groups were 48.3, 43.4, and 20.7, for reductions in the incidence of colorectal cancer of 90, 88, and 76 percent, respectively (P < 0.001). CONCLUSIONS: Colonoscopic polypectomy resulted in a lower-than-expected incidence of colorectal cancer. These results support the view that colorectal adenomas progress to adenocarcinomas, as well as the current practice of searching for and removing adenomatous polyps to prevent colorectal cancer.


Subject(s)
Adenocarcinoma/prevention & control , Adenomatous Polyps/surgery , Colonic Neoplasms/surgery , Colonoscopy , Colorectal Neoplasms/prevention & control , Rectal Neoplasms/surgery , Adenocarcinoma/epidemiology , Adult , Aged , Aged, 80 and over , Cohort Studies , Colonic Neoplasms/epidemiology , Colonic Neoplasms/prevention & control , Colorectal Neoplasms/epidemiology , Female , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Poisson Distribution , Rectal Neoplasms/epidemiology , Rectal Neoplasms/prevention & control , Retrospective Studies , Risk Factors
5.
J Surg Res ; 55(3): 249-55, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8412106

ABSTRACT

Immunohistologic techniques were used to study the expression of colorectal carcinoma-associated antigens in colonic polyps and to compare this with expression in the normal colonic epithelium. Forty-nine polyps were studied using monoclonal antibodies to 16 different blood group and differentiation antigens and carcinoembryonic antigen epitopes. With the Lewis(a) antigen and the two epitopes of CEA recognized by 3D6 and COL-4 expression in polyp tissue was the same as that in the normal colon. Five types of alteration of antigen expression in polyps were seen. The blood group antigens A, B, and Lewis(b), which are expressed only on the right side of the normal adult colon, were detected in both neoplastic and nonneoplastic polyps from the distal colon. The Lewis(x) antigen and the antigen epitopes detected by the antibodies COL-12, CA19-9, ME491, and GA73.3 showed an increased frequency of expression in all types of polyps in comparison with the normal colonic epithelium, while H-type 2, ND4, and the antigen epitope detected by CO29.11 showed a slightly decreased frequency of expression in polyp tissue. The X-like antigen which was expressed in only 7% of normal colon specimens showed increased frequency of expression in polyp tissue with significantly greater expression in neoplastic than hyperplastic lesions (P = 0.003). The TAG-72 antigen was detected only in adenomas with severe dysplasia (P = 0.01), correlating well with premalignant histology. These findings have helped us clarify the variation of antigen expression in colonic polyps and allowed us to define which antigens are worthy of further investigation as markers of possible malignant transformation.


Subject(s)
Antigens, Neoplasm/analysis , Colonic Polyps/immunology , Colorectal Neoplasms/immunology , ABO Blood-Group System/analysis , Antibodies, Monoclonal , Carcinoembryonic Antigen/analysis , Colonic Polyps/pathology , Glycoproteins/analysis , Humans , Immunoenzyme Techniques , Lewis Blood Group Antigens/analysis
6.
Am J Clin Pathol ; 99(6): 729-35, 1993 Jun.
Article in English | MEDLINE | ID: mdl-8322709

ABSTRACT

Measurement of the relative contributions of morphology alone; minimal essential clinical data; immunohistologic reactivity of a prototypic tumor marker, carcinoembryonic antigen (CEA); and the process by which a pathologist can identify the origin of a metastatic adenocarcinoma of unknown primary site is the subject of this report. To standardize the case material, we used an image digitizing and archival system to present 100 metastatic adenocarcinomas of known primary site as unknowns to two pathologists. The images were selected to show only gland-forming areas of the carcinomas and excluded all normal tissue elements. They were viewed, initially without, and then with, identification of gender and metastatic site. Subsequently, the results of immunoperoxidase staining for CEA, assessed independently by a third pathologist, were provided. Our analysis showed that, overall, the correct primary site was chosen as choice 1, 2, or 3 in 72% and 76%, and as choice 1 in 49% and 47% of cases, respectively. Accuracy was highest for prostatic, ovarian, and breast carcinomas, and lowest for upper-gastrointestinal tract, biliary tract, and pancreatic adenocarcinoma. Statistical analysis showed the largest increments in accuracy in the choice 1 prediction in each tumor category were achieved by provision of minimal essential clinical data. Knowledge of CEA status did not affect overall accuracy; however, it increased the odds of making the correct diagnosis for ovarian, colorectal, and endometrial (both pathologists) carcinomas, and for prostatic, pulmonary and esophago-gastric adenocarcinomas (one pathologist). The study exemplifies a model for the objective measurement of the contribution of ancillary studies, such as immunoperoxidase markers, to the accuracy of pathologic diagnosis.


Subject(s)
Adenocarcinoma/pathology , Adenocarcinoma/secondary , Carcinoembryonic Antigen/analysis , Lymphatic Metastasis/pathology , Neoplasms, Unknown Primary/pathology , Breast Neoplasms/pathology , Endometrial Neoplasms/pathology , Esophageal Neoplasms/pathology , Female , Gallbladder Neoplasms/pathology , Gastrointestinal Neoplasms/pathology , Humans , Lung Neoplasms/pathology , Male , Ovarian Neoplasms/pathology , Pancreatic Neoplasms/pathology , Probability , Prostatic Neoplasms/pathology
8.
Cancer ; 70(5 Suppl): 1236-45, 1992 Sep 01.
Article in English | MEDLINE | ID: mdl-1511370

ABSTRACT

The National Polyp Study (NPS) is a multicenter prospective randomized trial designed to evaluate follow-up surveillance strategies in patients who have undergone polypectomy for the control of large bowel cancer. The study design was developed by a joint research committee from American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the American College of Gastroenterology. Subjects who met the eligibility criteria were randomized into two different treatment arms. Eligibility criteria included: removal of one or more adenomas; complete colonoscopy; no prior polypectomy, inflammatory bowel disease, or familial polyposis; and no history of colon cancer. The treatment arms consisted of a frequent follow-up (1 and 3 years after initial polypectomy) and a less frequent follow-up (3 years). Follow-up examinations included fecal occult blood tests, air-contrast barium enema, and colonoscopy. The latter was done on 9112 referred patients at the seven participating centers from November 1980 until February 1990 who had no history of polypectomy, colon cancer, familial polyposis, or inflammatory bowel disease. Of these patients, 4763 (52.3%) had no polyps; 549 (6.0%) had an invasive cancer; 776 (8.5%) had nonadenomatous polyps; 208 (2.3%) had incomplete examinations; 184 (2.0%) had other findings; and 2632 (28.9%) had one or more adenomas, of which 1418 (53.9%) were randomized to one of the two treatment arms. This article reports the background, rationale, objectives, methods, and organization of this study and includes patient characteristics on initial presentation. Future data provided by the NPS may help in the development of recommendations for surveillance guidelines for such patients. This study also provides a framework to address questions regarding the natural history of adenomas and their relationship with colorectal cancer.


Subject(s)
Colonic Polyps/diagnosis , Colorectal Neoplasms/diagnosis , Adenoma/diagnosis , Barium Sulfate , Colonoscopy , Enema , Evaluation Studies as Topic , Female , Follow-Up Studies , Humans , Male , Middle Aged , Occult Blood , Prospective Studies
9.
Cancer ; 70(5 Suppl): 1317-27, 1992 Sep 01.
Article in English | MEDLINE | ID: mdl-1511379

ABSTRACT

The term biologic marker (biomarker) of colorectal cancer refers in this article to an early preclinical phenotypic characteristic that relates to the risk for developing this cancer. Putative biologic markers in the normal colorectal mucosa of patients at risk include abnormal cell proliferation as determined by kinetic studies, ornithine decarboxylase activity, and polyamine synthesis. Alterations of mucin synthesis have been studied using both histochemical stains and lectin-binding techniques. Blood group and related carbohydrate antigens also have been evaluated as potential biomarkers in the normal mucosa. Biopsy small (less than 5 mm) polyps encountered at endoscopy has become a standard practice. Although a small polyp found to be an adenoma has a low likelihood of harboring high-grade dysplasia or invasive carcinoma, it represents an indicator of risk for colorectal neoplasia. Hyperplastic polyps, however, even though they have certain epidemiologic associations with colorectal neoplasia, are controversial as putative biomarkers of clinical relevance. Current research supports a concept of a field defect of the colorectal mucosa at risk for neoplasia, which may be identified by phenotypic abnormalities of the normal mucosa and the development of small adenomas.


Subject(s)
Biomarkers, Tumor , Colorectal Neoplasms/pathology , Adenoma/pathology , Biomarkers, Tumor/analysis , Biopsy , Colonic Polyps/pathology , Humans , Phenotype , Precancerous Conditions/pathology
10.
Hum Pathol ; 23(9): 1038-43, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1381333

ABSTRACT

The relationship of villous to tubular adenomas is poorly understood and often difficult to characterize morphologically. A villous growth pattern in colorectal adenomas has been associated with a higher frequency of high-grade dysplasia. We compared phenotypic markers using immunoperoxidase techniques in paired samples of villous (75% to 100% villous) and pure tubular adenomas matched for size and degree of dysplasia, which were selected by review of 1,000 polyps from our files. The following monoclonal antibodies were used: CAM 5.2 and AE1/AE3 to cytokeratins; B18, D14, B7.1, and B7.8 to four distinct carcinoembryonic antigen epitopes; Leu-M1 and LN3 to HLA-DR antigen; LN2 to invariant chain class II major histocompatibility complex; LN1 and MB2 to B-cell markers; UCHL1 and MT1 to T-cell markers; Leu-7 to natural killer cells; Mac 387 to macrophages; S-100 to Langerhans-type cells; and a polyclonal antibody to secretory component. LN3 reactivity correlated with villous morphology and secretory component correlated with tubular morphology. Combined HLA-DR and secretory component expression discriminated between tubular and villous growth patterns in 12 of 15 pairs of adenomas (P less than .001). LN2 was expressed more frequently than LN3, but did not correlate with growth pattern. Neuroendocrine cells (Leu-7) were more frequent in tubular adenomas. Carcinoembryonic antigen epitopes did not relate to growth pattern. We did not confirm previously reported differences in cytokeratin expression. We concluded that among the markers tested, HLA-DR expression, which may have an immunologic basis, is most characteristic of colorectal adenomas that exhibit a villous growth pattern.


Subject(s)
Adenoma/metabolism , Colorectal Neoplasms/metabolism , Lymphoid Tissue/immunology , Adenoma/genetics , Adenoma/pathology , Antigens, Neoplasm/analysis , Biomarkers, Tumor , Carcinoembryonic Antigen/immunology , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Epithelium/immunology , Epitopes , Humans , Immunoenzyme Techniques , Phenotype , Staining and Labeling
11.
Am J Clin Pathol ; 94(2): 157-64, 1990 Aug.
Article in English | MEDLINE | ID: mdl-1695478

ABSTRACT

To evaluate the role of carcinoembryonic antigen (CEA) in solving problems of tumor histogenesis in surgical pathology, monoclonal antibodies to four distinct epitopes of CEA (E-Z-EM) were applied to paraffin sections of 303 epithelial neoplasms from multiple sites. Two epitopes were CEA specific (D14 and B7.1), one was shared with nonspecific cross-reacting antigen (NCA) (B7.8), and the fourth (B18) was common to CEA, NCA, and biliary glycoprotein antigen (BGP). A sample of the tumors (n = 110) was also stained with a polyclonal anti-CEA (DAKO). Gastrointestinal adenocarcinomas, including esophageal and gastric (n = 19), small intestinal (n = 8), colorectal (n = 56), biliary tract (n = 8), and pancreatic adenocarcinomas (n = 14), were consistently positive with all five antibodies. Other predominantly gland-forming carcinomas tested, comprising lung (n = 22), ovary (n = 18), and endometrium (n = 12), were either invariably negative with all five antibodies (endometrial adenocarcinoma, non-mucinous ovarian adenocarcinoma) or demonstrated selective and variable positivity (lung: D14, 50%; ovarian mucinous: D14, 50%). Among large polygonal cell carcinomas (hepatocellular carcinoma, renal cell carcinoma, melanoma, and adrenal carcinoma), only hepatomas stained positively, showing a distinctive canalicular staining pattern with the B18 (BGP epitope) (55%) and polyclonal antibody (50%). In the small polygonal cell carcinoma category, true CEA positivity was rare in breast (D14, 10% and B7.1, 14%) and never seen in prostatic carcinomas and carcinoid tumors. A subset of these breast (8 of 42), prostate (4 of 22), and carcinoids (4 of 7) showed exclusive positivity for the B18 antibody (NCA/BGP epitope). Ovarian serous papillary carcinomas (n = 14), papillary carcinomas of thyroid (n = 12), transitional cell carcinomas of the bladder (n = 11), and mesotheliomas (n = 3) were negative with all monoclonal antibodies. Metastatic carcinomas (n = 74) showed a similar pattern of reactivity to primary tumors. The authors conclude that CEA immunostaining may assist in identifying the histogenesis of epithelial tumors in several morphologic categories; that differential reactivities of the CEA monoclonal antibody panel exceed those of the polyclonal antibody; and that the discriminating power of the monoclonal panel is related to whether (1) CEA is or is not produced or (2) NCA or BGP is produced without concomitant CEA production. There is little evidence to support a concept of site-specific CEA species.


Subject(s)
Antibodies, Monoclonal , Antibodies, Neoplasm/immunology , Carcinoembryonic Antigen/immunology , Carcinoma/pathology , Carcinoma/immunology , Epitopes/immunology , Female , Humans , Immunoenzyme Techniques , Male , Neoplasm Metastasis
12.
Gastroenterology ; 98(2): 371-9, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2403953

ABSTRACT

The National Polyp Study (NPS), a randomized clinical trial to evaluate effective surveillance of patients discovered to have one or more colorectal adenomas, was the framework for this statistical analysis which used a multiple logistic model to assess the independent risk factors of patient and polyp characteristics associated with high-grade dysplasia in adenomas. The database included 3371 adenomas from 1867 patients. Adenoma size and the extent of the villous component were found to be the major independent polyp risk factors associated with high-grade dysplasia (p less than 0.0001). The adjusted odds ratios were 3.3 for medium-sized adenomas and 7.7 for large adenomas relative to small adenomas and 2.7 for villous A adenomas, 3.4 for villous B adenomas, and 8.1 for villous C and D adenomas relative to tubular adenomas. Increased frequency of high-grade dysplasia in adenomas located distal to the splenic flexure was attributable mainly to increased size and villous component rather than to location per se. The adjusted odds ratio was 1.4 (p less than 0.11) for left-sided location. Multiplicity of adenomas affected the risk for high-grade dysplasia in patients but was dependent on adenoma size and villous component and was not an independent factor. The adjusted odds ratio was 1.3 (p less than 0.17) for multiplicity. Increasing age was associated with risk for high-grade dysplasia in patients, and this effect was independent of the effect of adenoma size and histological type. The adjusted odds ratio was 1.8 (p less than 0.0016) for age greater than or equal to 60 yr. Gender was not associated with high-grade dysplasia. The adjusted odds ratio was 1.0 (p less than 0.95) for men. The size of the patient series, the prospective nature of the data collection, the completeness of information on all patients, the requirements of complete examination of the entire colon and pathological examination of all lesions encountered, and the exclusion of patients with previously diagnosed adenomas are, collectively, features unique to this study. The detailed model provided by the analysis integrates multiple patient and adenoma factors associated with high-grade dysplasia in colorectal adenomas.


Subject(s)
Adenoma/epidemiology , Colon/pathology , Colonic Polyps/epidemiology , Rectal Neoplasms/epidemiology , Rectum/pathology , Adenoma/pathology , Adult , Aged , Colonic Polyps/pathology , Female , Humans , Logistic Models , Male , Middle Aged , Multicenter Studies as Topic , Odds Ratio , Randomized Controlled Trials as Topic , Rectal Neoplasms/pathology , United States/epidemiology
13.
J Natl Cancer Inst ; 81(24): 1913-7, 1989 Dec 20.
Article in English | MEDLINE | ID: mdl-2593169

ABSTRACT

We used monoclonal antibody B72.3 to study the expression of the colorectal carcinoma-associated antigen TAG-72 in premalignant colonic lesions with the immunoperoxidase technique. This antigen, which is rarely detectable in the normal colonic epithelium, was expressed in 13 of 19 adenomas with moderate to severe dysplasia and nine of nine cases of inflammatory bowel disease. The antibody reacted with the normal-appearing mucosa adjacent to a carcinoma in 10 of 12 cases, although only eight of the tumors expressed the antigen. The expression of the TAG-72 antigen in the colonic epithelium may be an early marker of malignant transformation.


Subject(s)
Antigens, Neoplasm/analysis , Colorectal Neoplasms/immunology , Glycoproteins/analysis , Precancerous Conditions/immunology , Antibodies, Monoclonal , Colitis, Ulcerative/immunology , Colonic Polyps/immunology , Crohn Disease/immunology , Humans , Immunohistochemistry
15.
Gastroenterology ; 92(3): 682-92, 1987 Mar.
Article in English | MEDLINE | ID: mdl-3102307

ABSTRACT

A mathematical model was used to estimate the cost-effectiveness of colorectal cancer screening strategies for people who are at high risk because of a first-degree relative with colorectal cancer. The model uses indirect evidence about such factors as cancer incidence, sensitivity and specificity of different tests, and treatment effectiveness. The analysis indicates that for screening people over 40 yr old an annual fecal occult blood test may reduce colorectal cancer mortality by about one-third, either colonoscopy or barium enema may reduce mortality by approximately 85%, a 3-5-yr frequency for endoscopies or barium enemas preserves 70%-90% of the effectiveness of an annual frequency, and beginning screening at age 50 reduces effectiveness by 5%-10%. Although both barium enemas and colonoscopies appear to be effective in reducing mortality, the lower cost of the barium enema makes it a more cost-effective strategy. All of these estimates depend on the baseline estimates of each of the factors incorporated in the model; the conclusions are most sensitive to assumptions about the natural history of adenomatous polyps, the bleeding of adenomas and presymptomatic cancers, and the sensitivity of the fecal occult blood test. Recommendations about colorectal cancer screening must also consider factors such as discomfort, inconvenience, and the availability of various technologies.


Subject(s)
Colonic Neoplasms/epidemiology , Mass Screening/economics , Rectal Neoplasms/epidemiology , Colonic Neoplasms/genetics , Cost-Benefit Analysis , Humans , Models, Theoretical , Occult Blood , Rectal Neoplasms/genetics , Risk
16.
Am Fam Physician ; 31(6): 113-7, 1985 Jun.
Article in English | MEDLINE | ID: mdl-4013959

ABSTRACT

In the past decade, the incidence of tuberculosis morbidity has been halved. Nonetheless, an estimated 15 million Americans are infected with tubercle bacilli. Care of the tuberculous patient has moved from sanatoriums to general hospitals and homes. The declining incidence makes the diagnosis less often considered, especially since the classic signs are not always present.


Subject(s)
Tuberculosis, Pulmonary , Adult , Child , Child, Preschool , Female , Humans , Infant , Lymphatic Diseases/physiopathology , Male , Middle Aged , Pleural Effusion/diagnostic imaging , Radiography , Time Factors , Tuberculin Test , Tuberculosis, Miliary/diagnostic imaging , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Pulmonary/etiology , Tuberculosis, Pulmonary/transmission
17.
Am J Med ; 78(2): 195-202, 1985 Feb.
Article in English | MEDLINE | ID: mdl-2982259

ABSTRACT

The incidence and clinicopathologic features of early gastric cancer encountered among surgical specimens from gastric resections for carcinoma in a recent three-year period, 1977 to 1979, at the Mallory Institute of Pathology were studied and compared with those of a pre-endoscopic period 10 years earlier, 1967 to 1969. It was found that early gastric cancer now comprises a greatly increased proportion of lesions leading to gastric resection, mainly as a result of endoscopy and biopsy of gastric ulcers of benign appearance. In the recent period, there were six early gastric cancers in a total of 22 gastric resection specimens compared with one in 27 gastric resections performed for carcinoma in the pre-endoscopy period. Five of the six patients in the recent period are alive without evidence of disease four to five years following surgical resection. The single patient in the earlier period died postoperatively. Applying the classification of the Japanese Endoscopic Society, there were three depressed or ulcerated lesions (type IIc or III), three elevated or polypoid lesions (type I or IIa), and a single flat lesion (type IIb). All three ulcerated lesions were interpreted as benign peptic ulcers on conventional upper gastrointestinal studies. Findings on endoscopic biopsy were positive in all cases (six of six). Although not encountered frequently in the United States, early gastric cancer, nonetheless, appears to be indistinguishable from the disease as it is described in Japan in terms of its pathologic morphology, growth patterns, coexistent or related lesions of the stomach, and curability by surgical resection. If early gastric cancer is to be recognized more frequently, knowledge of the disease and a high index of suspicion on the part of physicians are essential.


Subject(s)
Stomach Neoplasms/pathology , Adenocarcinoma/pathology , Adenocarcinoma/physiopathology , Adenocarcinoma/surgery , Adenocarcinoma, Mucinous/pathology , Adenocarcinoma, Mucinous/physiopathology , Adenocarcinoma, Mucinous/surgery , Adult , Aged , Carcinoma/pathology , Carcinoma/physiopathology , Carcinoma/surgery , Female , Fiber Optic Technology , Gastroscopy , Humans , Male , Middle Aged , Stomach Neoplasms/physiopathology , Stomach Neoplasms/surgery
19.
Chest ; 81(4): 449-52, 1982 Apr.
Article in English | MEDLINE | ID: mdl-6279361

ABSTRACT

Lung cancer has been a rare disease among the Indians of the southwestern United States. However, the advent of uranium mining in the area has been associated with an increased incidence of lung cancer among Navajo uranium miners. This study centers on Navajo men with lung cancer who were admitted to the hospital from February 1965 to May 1979. Of a total of 17 patients with lung cancer, 16 were uranium miners, and one was a nonminer. The mean value of cumulative radon exposure for this group was 1139.5 working level months (WLMs). The predominant cancer type was the small cell undifferentiated category (62.5 percent). The low frequency of cigarette smoking in this group supports the view that radiation is the primary cause of lung cancer among uranium miners and that cigarette smoking acts as a promoting agent.


Subject(s)
Carcinoma, Small Cell/etiology , Indians, North American , Lung Neoplasms/etiology , Mining , Neoplasms, Radiation-Induced/etiology , Uranium/adverse effects , Adult , Aged , Humans , Male , Middle Aged , Occupational Diseases/etiology , Radiation Dosage , Smoking
20.
Am J Clin Pathol ; 75(3): 283-90, 1981 Mar.
Article in English | MEDLINE | ID: mdl-7010989

ABSTRACT

Immunoperoxidase and immunofluorescence staining for carcinoembryonic antigen (CEA) was performed on paraffin and frozen sections, respectively, of colonic carcinomas (70), liver and lymph node metastases (20), mesenteric nodes (150), mucosa adjacent to carcinoma (40), colonic resection margins (20), normal colon (ten), and colorectal polyps (64) in order to assess its potential diagnostic value. On the basis of this study of the immunocytochemical localization of CEA in colorectal tissues, conclusions were as follows. (1) Localization of CEA to glycocalyx of surface epithelial cells is a normal finding in the colon and is similar in normal colon and mucosa distant and adjacent to infiltrating carcinoma. (2) Although strongly positive cell surface and intraluminal staining frequently correlates with the presence of carcinoma in neoplastic polyps, it is not by itself a reliable diagnostic criterion. (3) Failure to demonstrate CEA in a gland-forming carcinoma makes a diagnosis of colorectal carcinoma unlikely. (4) Poorly differentiated colorectal carcinoma usually contains much less demonstrable surface CEA, but may occasionally stain cytoplasm strongly. (5) Although lymph node micrometastases from colorectal carcinoma are readily demonstrated by immunoperoxidase staining for CEA, screening of hematoxylin and eosin-stained sections by a competent pathologist appears to be adequate for their detection.


Subject(s)
Carcinoembryonic Antigen/analysis , Colonic Neoplasms/immunology , Rectal Neoplasms/immunology , Colonic Neoplasms/diagnosis , Humans , Immunoenzyme Techniques , Intestinal Mucosa/pathology , Lymphatic Metastasis , Polyps/immunology , Rectal Neoplasms/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...